China Life Insurance: Positive Reactions to First Quarter Results

China Life Insurance reported a 34.4% year-on-year decline in 1Q net income, though analysts saw a bright spot...

Article Default

China Life Insurance, one of the largest Chinese insurance groups, announced that 1Q net income dropped 34.4% on year to 17.09 billion yuan while operating income grew 8.2% to 33.78 billion yuan on insurance revenue of 307.78 billion yuan, up 13.0%. While headline results showed the negative impacts of coronavirus, decline in equity markets and a downward trend in interest rates, a spotlight was placed on new business value which grew 8.3% on year.  Chinese investment bank CICC said new business value was better than the company's rivals and sees growth "significantly outpacing" peers in 2020.

From a technical point of view, China Life Insurance H share (2628.HK) is extending its rebound as shown on the daily chart. It has broken above a bearish trend line drawn from January, after forming a bullish flag pattern in March. Bullish investors might consider $14.70 as the nearest support, with prices likely to advance to the 1st and 2nd resistance at $17.30 and $18.50 respectively, filling the gaps previously made in early March. In an alternatively scenario, a break below $14.70 may trigger a pull-back to the next support at $13.50.

Source: TradingView, GAIN Capital

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.